Methyl-Modified Iridium Complex for Pure Red OLED Emission
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional organoiridium complexes used as red phosphorescent materials in OLEDs suffer from low photoluminescence quantum yield (ΦPL) and inadequate color purity, making it difficult to achieve both high emission efficiency and pure red color emission.
Innovation Solution
An organoiridium complex is developed, where a methyl group is introduced into the 2-(dibenzo[b,d]thiophen-4-yl)quinolinate ligand, specifically in the dibenzothiophene moiety, to enhance the photoluminescence quantum yield and shift the light emission wavelength to a longer wavelength, achieving pure red phosphorescence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional organoiridium complexes are used as red phosphorescent materials, then the device structure can be maintained, but the photoluminescence quantum yield is low and color purity is inadequate
Solution Approach 1:
The patent modifies the chemical structure parameters of the organoiridium complex by introducing a methyl group at the 2-position of the dibenzothiophene moiety in the C-N ligand. This structural parameter change leads to improved photoluminescence quantum yield (ΦPL exceeding 0.70 in PMMA thin film) and enhanced color purity with emission wavelength exceeding 630 nm, while maintaining the overall device structure of the OLED
2Productivity
If conventional organoiridium complexes are used, then the basic emission function is achieved, but the emission efficiency and color purity cannot be simultaneously optimized
Solution Approach 1:
The patent applies local quality modification by introducing a methyl group specifically at the 2-position of the dibenzothiophene moiety in the C-N ligand structure. This localized structural modification optimizes both the emission efficiency (ΦPL > 0.70) and color purity (emission wavelength > 630 nm) simultaneously, demonstrating that targeted local changes can achieve multiple performance improvements
3Manufacturing precision
If red phosphorescent materials with longest light emission wavelength are used, then color purity is improved, but photoluminescence quantum yield decreases
Solution Approach 1:
The patent creates a composite organoiridium complex structure combining iridium metal center with a specifically modified C-N ligand containing dibenzothiophene moiety with 2-position methyl group. This composite structure achieves synergistic effect where the metal center provides phosphorescence activity while the modified ligand structure ensures both long emission wavelength ( > 630 nm for pure red color) and high photoluminescence quantum yield (ΦPL > 0.70), resolving the trade-off between color purity and emission efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified organoiridium complex exhibits significantly improved photoluminescence quantum yield and color purity, making it suitable for use as a red phosphorescent material in OLEDs, with enhanced emission efficiency and pure red light emission.
Implementation Method 1
the present invention relates to a technique that provides an organoiridium complex suitable as a phosphorescent material for an organic electroluminescent element
Data Source
AI summary
The present invention relates to an organoiridium complex for an organic electroluminescent element in which a C—N ligand and an ancillary ligand are coordinated with iridium. This organoiridium complex contains a 2-(dibenzo[b,d]thiophen-4-yl)quinolinate ligand having at least one methyl group introduced thereinto coordinated as the C—N ligand, and is represented by the following Formula. The present inventive organoiridium complex is suitable as a red emitting phosphorescent material for an OLED, has high photoluminescence quantum yield ΦPL, and is excellent in color purity.(In the aforementioned Formula, R1, R2, R3, R4, R5, R6, and R7 are each a methyl group or a hydrogen atom, provided that at least one of R1, R2, R3, R4 is a methyl group; and X—Y is the ancillary ligand.)